Success factors and measures for scaling patient-facing digital health technologies from leaders’ insights

Abstract Background Europe’s healthcare systems face a triple burden: the rise of non-communicable diseases (NCDs), an aging population, and a shortage of healthcare professionals. NCDs, the leading causes of death, disproportionately affect older adults, placing significant pressure on healthcare s...

Full description

Saved in:
Bibliographic Details
Main Authors: Estelle Pfitzer, Odile Giger, Christoph Kausch, Tobias Kowatsch
Format: Article
Language:English
Published: BMC 2025-05-01
Series:BMC Health Services Research
Subjects:
Online Access:https://doi.org/10.1186/s12913-025-12748-z
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849402926631485440
author Estelle Pfitzer
Odile Giger
Christoph Kausch
Tobias Kowatsch
author_facet Estelle Pfitzer
Odile Giger
Christoph Kausch
Tobias Kowatsch
author_sort Estelle Pfitzer
collection DOAJ
description Abstract Background Europe’s healthcare systems face a triple burden: the rise of non-communicable diseases (NCDs), an aging population, and a shortage of healthcare professionals. NCDs, the leading causes of death, disproportionately affect older adults, placing significant pressure on healthcare services. By 2050, nearly 30% of Europe’s population will be aged 65 or older, up from 20% in 2023. These challenges demand urgent solutions to sustain healthcare systems. Patient-facing digital health technologies (DHTs), such as Digital Diagnostics and Digital Therapeutics, offer promising tools to address this burden by empowering patient self-management, reducing strain on healthcare professionals, and enhancing system efficiency. Despite their potential, the scaling and adoption of DHTs remain limited. This study investigates: (RQ1) What key factors drive success across different patient-facing DHT categories? and (RQ2) How can companies implement these factors? Methods Following COREQ guidelines, we conducted semi-structured interviews with 29 executives and founders of European DHT companies targeting NCDs. Participants were identified using PitchBook, focusing on revenue-generating companies with over 20 employees. Virtual interviews were conducted in English between May and September 2024, lasting an average of 28 min (range: 21–40). Data saturation determined the sample size. Thematic analysis was performed, with two researchers independently coding the data to ensure reliability. Success factors were categorized as internal (e.g., employees) or external (e.g., partnerships). Ethical approval was obtained, and data was anonymized. A follow-up survey (n = 27) was conducted to confirm our findings. Results We identified 18 success factors for scaling patient-facing DHTs. Health & Wellness companies prioritized business model flexibility, while Digital Therapeutics relied on regulatory compliance. Validation of health impact was critical across categories, emphasized by all respondents in Digital Diagnostics and Digital Therapeutics. Other key factors included customer awareness, strategic partnerships, and investor alignment, highlighting the importance of tailored growth strategies. Conclusion This study provides structured guidance for scaling patient-facing DHTs, emphasizing category-specific strategies aligned with operational, regulatory, and consumer demands. It offers actionable recommendations for founders and executives to allocate resources effectively and adapt to diverse market contexts. By addressing the unique challenges of scaling DHTs, this work contributes to advancing digital health research and improving healthcare system resilience.
format Article
id doaj-art-cdc0e0eab32e4300a584a7339ed53ec8
institution Kabale University
issn 1472-6963
language English
publishDate 2025-05-01
publisher BMC
record_format Article
series BMC Health Services Research
spelling doaj-art-cdc0e0eab32e4300a584a7339ed53ec82025-08-20T03:37:23ZengBMCBMC Health Services Research1472-69632025-05-0125112010.1186/s12913-025-12748-zSuccess factors and measures for scaling patient-facing digital health technologies from leaders’ insightsEstelle Pfitzer0Odile Giger1Christoph Kausch2Tobias Kowatsch3Centre for Digital Health Interventions, School of Medicine, University of St. GallenCentre for Digital Health Interventions, School of Medicine, University of St. GallenMTIP AGCentre for Digital Health Interventions, School of Medicine, University of St. GallenAbstract Background Europe’s healthcare systems face a triple burden: the rise of non-communicable diseases (NCDs), an aging population, and a shortage of healthcare professionals. NCDs, the leading causes of death, disproportionately affect older adults, placing significant pressure on healthcare services. By 2050, nearly 30% of Europe’s population will be aged 65 or older, up from 20% in 2023. These challenges demand urgent solutions to sustain healthcare systems. Patient-facing digital health technologies (DHTs), such as Digital Diagnostics and Digital Therapeutics, offer promising tools to address this burden by empowering patient self-management, reducing strain on healthcare professionals, and enhancing system efficiency. Despite their potential, the scaling and adoption of DHTs remain limited. This study investigates: (RQ1) What key factors drive success across different patient-facing DHT categories? and (RQ2) How can companies implement these factors? Methods Following COREQ guidelines, we conducted semi-structured interviews with 29 executives and founders of European DHT companies targeting NCDs. Participants were identified using PitchBook, focusing on revenue-generating companies with over 20 employees. Virtual interviews were conducted in English between May and September 2024, lasting an average of 28 min (range: 21–40). Data saturation determined the sample size. Thematic analysis was performed, with two researchers independently coding the data to ensure reliability. Success factors were categorized as internal (e.g., employees) or external (e.g., partnerships). Ethical approval was obtained, and data was anonymized. A follow-up survey (n = 27) was conducted to confirm our findings. Results We identified 18 success factors for scaling patient-facing DHTs. Health & Wellness companies prioritized business model flexibility, while Digital Therapeutics relied on regulatory compliance. Validation of health impact was critical across categories, emphasized by all respondents in Digital Diagnostics and Digital Therapeutics. Other key factors included customer awareness, strategic partnerships, and investor alignment, highlighting the importance of tailored growth strategies. Conclusion This study provides structured guidance for scaling patient-facing DHTs, emphasizing category-specific strategies aligned with operational, regulatory, and consumer demands. It offers actionable recommendations for founders and executives to allocate resources effectively and adapt to diverse market contexts. By addressing the unique challenges of scaling DHTs, this work contributes to advancing digital health research and improving healthcare system resilience.https://doi.org/10.1186/s12913-025-12748-zDigital health technologiesPatient-facing solutionsSuccess factorsScaling strategiesNon-communicable diseases
spellingShingle Estelle Pfitzer
Odile Giger
Christoph Kausch
Tobias Kowatsch
Success factors and measures for scaling patient-facing digital health technologies from leaders’ insights
BMC Health Services Research
Digital health technologies
Patient-facing solutions
Success factors
Scaling strategies
Non-communicable diseases
title Success factors and measures for scaling patient-facing digital health technologies from leaders’ insights
title_full Success factors and measures for scaling patient-facing digital health technologies from leaders’ insights
title_fullStr Success factors and measures for scaling patient-facing digital health technologies from leaders’ insights
title_full_unstemmed Success factors and measures for scaling patient-facing digital health technologies from leaders’ insights
title_short Success factors and measures for scaling patient-facing digital health technologies from leaders’ insights
title_sort success factors and measures for scaling patient facing digital health technologies from leaders insights
topic Digital health technologies
Patient-facing solutions
Success factors
Scaling strategies
Non-communicable diseases
url https://doi.org/10.1186/s12913-025-12748-z
work_keys_str_mv AT estellepfitzer successfactorsandmeasuresforscalingpatientfacingdigitalhealthtechnologiesfromleadersinsights
AT odilegiger successfactorsandmeasuresforscalingpatientfacingdigitalhealthtechnologiesfromleadersinsights
AT christophkausch successfactorsandmeasuresforscalingpatientfacingdigitalhealthtechnologiesfromleadersinsights
AT tobiaskowatsch successfactorsandmeasuresforscalingpatientfacingdigitalhealthtechnologiesfromleadersinsights